This inventor holds 1 USPTO granted patent. Top assignee: Hexachimie. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: The Innovations of Bernard Schwiesguth
Introduction
Bernard Schwiesguth is a notable inventor based in Meudon, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on morpholine derivatives. His research focuses on compounds that exhibit interesting therapeutic properties, especially concerning the central nervous system.
Latest Patents
Schwiesguth holds a patent for "Morpholine containing imidzo[4,5-b]pyridines and use thereof." This patent includes morpholine derivatives characterized by specific chemical structures, where Z can be CH or N, and Y can be hydrogen, halogen, or alkyl groups of 1 to 4 carbon atoms. The compounds also include various alkoxy groups and have potential applications in medicine due to their non-toxic, pharmaceutically acceptable acid addition salts.
Career Highlights
Throughout his career, Schwiesguth has been associated with Hexachimie, a company that focuses on chemical innovations. His work has contributed to advancements in therapeutic agents, showcasing his expertise in medicinal chemistry.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Bernard Schwiesguth's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor in the industry. His work continues to influence therapeutic developments, particularly in the treatment of central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile